Financials
Income statement
Fiscal date | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 |
---|---|---|---|---|
Total reported revenue | — | 1.8T | 1.7T | 1.7T |
Cost of revenue | — | 1.5T | 1.4T | 1.3T |
Gross profit | — | 368.1B | 334.7B | 333.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | 252.4B | 234.9B | 221.4B |
Other operating expenses | — | 19.1B | 7.8B | 2.8B |
Operating income | — | 115.7B | 92.0B | 108.7B |
Non operating interest income | ||||
Income | — | 20.5B | 18.5B | 17.4B |
Expense | — | 22.8B | 22.2B | 23.1B |
Other income expense | — | — | — | — |
Pretax income | — | 24.9B | 155.4B | 188.2B |
Tax provision | — | 29.3B | 26.7B | 23.5B |
Net income | — | -4.3B | 128.7B | 164.7B |
Basic EPS | 103.9 | — | 97.5 | 127.2 |
Diluted EPS | 103.8 | — | 97.5 | 127.1 |
Basic average shares | 1.2B | — | 1.2B | 1.2B |
Diluted average shares | 1.2B | — | 1.2B | 1.2B |
EBITDA | — | 132.2B | 226.6B | 257.7B |
Net income from continuing op. | — | -4.3B | 128.7B | 164.7B |
Minority interests | — | -13.4B | -9.4B | -9.3B |
Preferred stock dividends | — | 0 | 0 | 0 |